Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B

The immunogenicity and safety of a new recombinant hepatitis B vaccine from the Instituto Butantan (Butang®) were evaluated in a multicenter, double-blind, prospective equivalence study in three centers in Brazil. Engerix B® was the standard vaccine. A total of 3937 subjects were recruited and 2754...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Reinaldo Menezes Martins, Gilberta Bensabath, Luiz Claudio Arraes, Maria de Lourdes Aguiar Oliveira, Juliana Custódio Miguel, Glayse Glayde Barbosa, Luiz Antonio Bastos Camacho
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Fundação Oswaldo Cruz (FIOCRUZ) 2004-12-01
Σειρά:	Memorias do Instituto Oswaldo Cruz
Θέματα:	hepatitis B vaccine recombinant vaccines immunization
Διαθέσιμο Online:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000800014
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!